My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about James Lanthier

Recent news which mentions James Lanthier

Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
Tickers MSSTF
Tags psilocin Psychedelics James Lanthier
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
Tickers CYBN MSSTF
Tags Psychedelics CYBN James Lanthier
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Markets MHRA Legal
From Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
Tickers MSSTF
Tags MSSTF News intellectual property
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Tickers MSSTF
Tags Drug Discovery Psychedelics James Lanthier
From Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
Tickers MSSTF
Tags psychedelic medicines James Lanthier Drug Discovery
From Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
Tickers MSSTF
Tags James Lanthier Centre for Addiction and Mental Health WHO
From Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
Tickers MSSTF
Tags Market News Psychedelics the United States Patent and Trademark Office
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.